Researchers Launch Clinical Trial for Ebola Treatments as Congo Outbreak Continues

KINSHASA: Researchers have launched a new clinical study to evaluate two potential treatments for Ebola virus disease as the ongoing outbreak in the Democratic Republic of the Congo (DRC) continues to affect communities.

The World Health Organization (WHO) confirmed that the first participant has been enrolled in the trial, marking an important step in efforts to identify effective treatment options for the current outbreak.

Outbreak Caused by Rare Ebola Strain

According to the WHO, the outbreak is linked to the Bundibugyo strain of the Ebola virus, which is less common than other known Ebola variants. At present, there are no approved vaccines or treatments specifically developed for this strain.

Health officials reported that more than 1,400 confirmed cases have been identified during the outbreak, with 438 deaths recorded so far. At the same time, over 200 patients have recovered, highlighting the importance of early medical care and supportive treatment.

Two Potential Treatments Under Evaluation

The clinical trial will assess the effectiveness of two treatment candidates:

• Remdesivir, an antiviral medication that has previously been used to treat certain viral infections and has shown potential in laboratory studies against the Bundibugyo strain.
• MBP134, an investigational antibody-based therapy designed to target multiple Ebola virus species, including the Bundibugyo variant.

Researchers hope the study will determine whether either treatment can improve survival rates among patients infected during the outbreak.

WHO Highlights Importance of Research

WHO Director-General Tedros Adhanom Ghebreyesus said the study represents an important opportunity to strengthen the global response to Ebola and provide evidence-based treatment options for affected communities.

Health experts continue to emphasize that early diagnosis, supportive medical care, infection prevention measures, and ongoing research remain essential in controlling the outbreak and reducing its impact.